How this company measures up on the fundamentals that matter
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
https://www.unitedhealthgroup.com
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Trading at $392, 57% above fair value of $249. Passes all ethical screens. Ranks better than 46% of screened stocks.
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Trading characteristics and market positioning
Balance sheet strength and cash generation — the foundation of long-term value
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-27 | SMITH JANE A | Director | Purchase | 500 | $245,000 |
| 2026-05-26 | DOE JOHN B | CEO | Award/Grant | 2,000 | — |
| 2026-05-25 | BROWN MARY K | CFO | Option Exercise | 1,500 | $675,000 |
| 2026-05-24 | WHITE PETER L | EVP | Tax Withholding | 700 | $336,000 |
| 2026-05-23 | GREEN ANNA M | Director | Gift | 300 | — |
| 2025-05-31 | JONES DAVID P | EVP | Purchase | 100 | $40,000 |
| 2026-04-23 | CONWAY PATRICK HUGH M.D. | Officer | 800 | $284,000 | |
| 2026-04-01 | GARCIA PAUL REU | Director | 343 | — | |
| 2026-04-01 | HOOPER MICHELE J. | Director | 206 | — | |
| 2026-04-01 | BAKER CHARLES D | Director | 343 | — |
Congressional trading disclosures involving this instrument
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15